• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Crescita Therapeutics Inc (TSX: CTX )

    0.5900 -0.0100 (-1.67%)
    Streaming Delayed Price Updated: 2:34 PM EDT, Sep 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,195
    Open 0.6000
    Bid (Size) 0.5900 (330)
    Ask (Size) 0.6000 (60)
    Prev. Close 0.6000
    Today's Range 0.5900 - 0.6000
    52wk Range 0.3600 - 0.6900
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
    From Crescita Therapeutics
    Via Business Wire
    Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver
    Via ACCESSWIRE

    Performance

    YTD
    +20.41%
    +20.41%
    1 Month
    -10.61%
    -10.61%
    3 Month
    +13.46%
    +13.46%
    6 Month
    +37.21%
    +37.21%
    1 Year
    -6.35%
    -6.35%

    More News

    Read More
    Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024
    From Crescita Therapeutics
    Via Business Wire
    Crescita Reports Second Quarter 2024 Results
    From Crescita Therapeutics
    Via Business Wire
    Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years
    From Crescita Therapeutics
    Via Business Wire
    Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement
    From Crescita Therapeutics
    Via Business Wire
    Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device
    From Crescita Therapeutics
    Via Business Wire
    Crescita Completes Acquisition of Strategic Assets of Occy Laboratory
    From Crescita Therapeutics
    Via Business Wire
    Crescita to Acquire Strategic Assets of Occy Laboratory
    From Crescita Therapeutics
    Via Business Wire
    Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
    From Crescita Therapeutics
    Via Business Wire
    Crescita Reports First Quarter 2024 Results
    From Crescita Therapeutics
    Via Business Wire
    Crescita Reports Q4 and Fiscal 2023 Results
    From Crescita Therapeutics
    Via Business Wire
    Crescita Reports Third Quarter 2023 Results
    From Crescita Therapeutics Inc.
    Via Business Wire
    Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
    From Crescita Therapeutics
    Via Business Wire
    Crescita Reports Second Quarter 2023 Results
    From Crescita Therapeutics
    Via Business Wire
    Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
    From Crescita Therapeutics
    Via Business Wire
    Crescita Reports First Quarter 2023 Results
    From Crescita Therapeutics Inc.
    Via Business Wire
    Crescita Reports Q4 and Fiscal 2022 Results
    From Crescita Therapeutics Inc.
    Via Business Wire
    Crescita Reports Third Quarter 2022 Results
    From Crescita Therapeutics Inc.
    Via Business Wire
    Crescita Reports Second Quarter 2022 Results
    From Crescita Therapeutics Inc.
    Via Business Wire
    Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
    From Crescita Therapeutics
    Via Business Wire
    Crescita Reports First Quarter 2022 Results
    From Crescita Therapeutics
    Via Business Wire
    Crescita to Present at Bloom Burton & Co. Healthcare Investor Conference
    From Crescita Therapeutics
    Via Business Wire
    Crescita Reports Q4 and Fiscal 2021 Results
    From Crescita Therapeutics Inc.
    Via Business Wire
    Crescita Therapeutics Announces Renewal of Normal Course Issuer Bid
    From Crescita Therapeutics
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.